4.7 Article

Synthetic RNA Modulators in Drug Discovery

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 64, 期 11, 页码 7110-7155

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.1c00154

关键词

-

资金

  1. Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)
  2. Project for Cancer Research and Therapeutic Evolution
  3. Naito Foundation
  4. JSPS

向作者/读者索取更多资源

RNAs play crucial roles in cellular processes and dysfunction can lead to various disorders. Utilizing compounds that bind RNAs and modulate their functions is a promising approach for developing innovative therapies.
RNAs are involved in an enormous range of cellular processes, including gene regulation, protein synthesis, and cell differentiation, and dysfunctional RNAs are associated with disorders such as cancers, neurodegenerative diseases, and viral infections. Thus, the identification of compounds with the ability to bind RNAs and modulate their functions is an exciting approach for developing next-generation therapies. Numerous RNA-binding agents have been reported over the past decade, but the design of synthetic molecules with selectivity for specific RNA sequences is still in its infancy. In this perspective, we highlight recent advances in targeting RNAs with synthetic molecules, and we discuss the potential value of this approach for the development of innovative therapeutic agents.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据